Cardiff Oncology shares plunge after Q2 earnings miss
Sasol (NYSE:SSL) Limited (JSE:SOL, NYSE: SSL), a major player in the energy and chemical industries, reported transactions by its executives in a filing with the U.S. Securities and Exchange Commission (SEC). The report, dated May 29, 2025, detailed trades made by an executive director and a prescribed officer of the company.
On May 26, 2025, Sasol’s Executive Director and CEO, S Baloyi, and a prescribed officer, V Bester, engaged in transactions involving Sasol ordinary shares. These dealings were part of the long-term incentive plan established in 2016, with certain shares vesting based on the achievement of corporate performance targets.
Baloyi retained 7,186 vested shares at a price of ZAR 79.95 per share, with a total transaction value of ZAR 574,521. Bester also retained shares and sold a portion on the market. Bester sold 3,037 shares at an average price of ZAR 85.9874 each, totaling ZAR 261,144, to cover tax liabilities and transaction costs associated with the vested shares. The remaining vested shares were retained in accordance with the company’s minimum shareholding requirements.
The transactions were conducted in compliance with the JSE Limited Listings Requirements, and all necessary clearances were obtained. The highest, lowest, and volume-weighted average prices for Sasol shares on May 26, 2025, were ZAR 89.5600, ZAR 85.5500, and ZAR 85.9874, respectively.
The disclosure of these transactions is a regulatory requirement meant to maintain transparency in the dealings of company insiders. This information is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.